Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-04-13
2010-06-29
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S109000
Reexamination Certificate
active
07745436
ABSTRACT:
This invention relates to disalt nitrogen-heteroaryl inhibitors of IL-12 production, and related methods and pharmaceutical compositions.
REFERENCES:
patent: 6384032 (2002-05-01), Ono et al.
patent: 6680315 (2004-01-01), Ono et al.
patent: 6693097 (2004-02-01), Ono et al.
patent: 6858606 (2005-02-01), Sun et al.
patent: 7045517 (2006-05-01), Ono et al.
patent: 7067514 (2006-06-01), Ono et al.
patent: 7465725 (2008-12-01), Ono et al.
patent: 7470681 (2008-12-01), Sun et al.
patent: 7470685 (2008-12-01), Sun et al.
patent: WO 2004/035740 (2004-04-01), None
King, Med Chem: Principle and Practice (1994), p. 206-208.
International Search Report in PCT International Application No. PCT/US05/12578.
Kostik Elena
Sun Lijun
Edwards Angell Palmer & & Dodge LLP
Hsi Jeffrey D.
Russett Mark D.
Solola Taofiq A
Synta Pharmaceuticals Corporation
LandOfFree
Disalt inhibitors of IL-12 production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Disalt inhibitors of IL-12 production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Disalt inhibitors of IL-12 production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207769